New study finds antidepressant drug effective in treating 'lazy eye' in adults

New study finds antidepressant drug effective in treating 'lazy eye' in adults
Ketamine reactivates adult ocular dominance plasticity and restores visual acuity in adult amblyopic subjects as shown in these cortical response maps. The top image shows results from control saline-treated test subjects and the bottom image shows the results of those treated with ketamine. Credit: University of California, Irvine

In a new study, published in Current Biology, researchers from the University of California, Irvine School of Medicine reveal how subanesthetic ketamine, which is used for pain management and as an antidepressant in humans, is effective in treating adult amblyopia, a brain disorder commonly known as 'lazy eye.'

"Our study demonstrates how a single-dose of subanesthetic reactivates adult visual cortical plasticity and promotes functional recovery of visual acuity defects resulting from amblyopia," explained Xiangmin Xu, Ph.D., a professor of anatomy and neurobiology and director of the Center for Neural Circuit Mapping at the UCI School of Medicine.

Subanesthetic ketamine, commonly used to treat depression and pain, evokes rapid and long-lasting antidepressant effects in human patients. There was evidence that ketamine may control how the makes structural changes in response to internal and external demands, a process called neural plasticity. But, how the drug worked remained elusive, until now.

"Our research team showed that ketamine down-regulates NRG1 expression in PV inhibitory cells, resulting in sustained cortical disinhibition to enhance cortical plasticity in adult visual cortex," said Steven F. Grieco, Ph.D., a postdoctoral scholar in the Xu lab and lead author.

"Through this neural plasticity-based mechanism, ketamine mediated functional recovery from adult ." Xin Qiao, Ph.D., a postdoctoral staff in the Xu lab is a co-first author for the published paper.

Amblyopia is a vision disorder in which the brain fails to process inputs from one eye, favoring the other eye. The condition can result in decreased vision in the affected eye. Each year, between one and five percent of children worldwide, are diagnosed with this condition.

Fast and sustained ketamine actions show promise for therapeutic applications that rely on reactivating adult cortical plasticity. Further testing is needed to determine the full implications of this discovery.

More information: Steven F. Grieco et al, Subanesthetic Ketamine Reactivates Adult Cortical Plasticity to Restore Vision from Amblyopia, Current Biology (2020). DOI: 10.1016/j.cub.2020.07.008

Journal information: Current Biology
Citation: New study finds antidepressant drug effective in treating 'lazy eye' in adults (2020, September 30) retrieved 17 July 2024 from https://medicalxpress.com/news/2020-09-antidepressant-drug-effective-lazy-eye.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Ketamine reduces drinking in male, but not female, rats

5 shares

Feedback to editors